[铁代谢和骨髓瘤中铁的研究进展]
Yudi Wang1,2, Weiying Feng3, Fudi Wang4
1Department of Hematology, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang Province, China. 183819142@qq.com.
概括
铁代谢和铁亡是髓状瘤发育和进展的关键因素. 针对这些过程为各种髓状瘤提供了有希望的新疗法策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 铁代谢失调在各种骨髓瘤瘤中观察到.
- 特定的铁代谢概况与急性髓性白血病和骨髓失质综合征的预后相关.
- 骨髓增殖性瘤通常伴有缺铁和红细胞瘤,这表明肝素是治疗点.
研究的目的:
- 审查铁代谢和铁死在髓状瘤中的作用.
- 阐明这些癌症中铁亡的机制.
- 为针对铁代谢和铁亡的新疗法提供基础.
主要方法:
- 关于铁代谢,铁和骨髓瘤瘤的研究的文献综述.
- 分析将铁失调与癌症发展联系在一起的机制.
- 检查费罗普托斯的抗瘤作用和治疗潜力.
主要成果:
- 骨髓状瘤细胞对氧化应激和铁灭症具有敏感性.
- 铁生体在急性髓性白血病和骨髓质综合征中表现出抗瘤活性.
- 向铁死可以克服慢性髓性白血病中的伊马替尼抗性.
结论:
- 铁代谢和铁亡在骨髓性瘤病变发生过程中至关重要.
- 这些途径代表了开发创新癌症疗法的可行目标.
- 对向铁亡的进一步研究可能会导致骨髓状细胞癌的治疗结果得到改善.
相关概念视频
Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K


